RJFSA
TNDM icon

Raymond James Financial Services Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Raymond James Financial Services Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$729K Buy
17,189
+494
+3% +$20.9K ﹤0.01% 2381
2024
Q2 		$673K Buy
16,695
+681
+4% +$28.4K ﹤0.01% 2336
2024
Q1 		$567K Buy
16,014
+169
+1% +$4.53K ﹤0.01% 2430
2023
Q4 		$469K Sell
15,845
-1,950
-11% -$40.5K ﹤0.01% 2472
2023
Q3 		$370K Sell
17,795
-1,351
-7% -$37.1K ﹤0.01% 2507
2023
Q2 		$470K Sell
19,146
-7,134
-27% -$230K ﹤0.01% 2382
2023
Q1 		$1.07M Buy
26,280
+7,850
+43% +$325K ﹤0.01% 1866
2022
Q4 		$828K Sell
18,430
-743
-4% -$33.6K ﹤0.01% 1964
2022
Q3 		$917K Sell
19,173
-445
-2% -$24.4K ﹤0.01% 1857
2022
Q2 		$1.16M Sell
19,618
-594
-3% -$48.8K ﹤0.01% 1742
2022
Q1 		$2.35M Sell
20,212
-10,480
-34% -$1.22M ﹤0.01% 1394
2021
Q4 		$4.62M Buy
30,692
+8,224
+37% +$1.11M 0.01% 1050
2021
Q3 		$2.68M Buy
22,468
+14,352
+177% +$1.58M 0.01% 1314
2021
Q2 		$790K Sell
8,116
-637
-7% -$56.8K ﹤0.01% 2101
2021
Q1 		$772K Buy
8,753
+2,021
+30% +$188K ﹤0.01% 2022
2020
Q4 		$644K Sell
6,732
-3,403
-34% -$351K ﹤0.01% 1983
2020
Q3 		$1.15M Buy
10,135
+441
+5% +$46.3K ﹤0.01% 1475
2020
Q2 		$959K Buy
+9,694
New +$774K ﹤0.01% 1516
2020
Q1 		– Sell
-3,509
Closed -$209K – 2826
2019
Q4 		$209K Sell
3,509
-46
-1% -$2.84K ﹤0.01% 2548
2019
Q3 		$210K Sell
3,555
-5,560
-61% -$355K ﹤0.01% 2470
2019
Q2 		$588K Buy
9,115
+3,961
+77% +$256K ﹤0.01% 1819
2019
Q1 		$327K Buy
+5,154
New +$271K ﹤0.01% 2179
2018
Q4 		– Sell
-7,798
Closed -$334K – 2826
2018
Q3 		$334K Buy
+7,798
New +$272K ﹤0.01% 2204

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Raymond James Financial Services Advisors's TNDM Position: Q3 2024 in Review

Raymond James Financial Services Advisors increased its Tandem Diabetes Care (TNDM) stake by 3% in Q3 2024, buying an estimated $20.9K and bringing the position to 17,189 shares worth $729K. The position accounts for ﹤0.01% of the portfolio, ranked #2381.

Raymond James Financial Services Advisors first reported a position in TNDM in Q3 2018 and has held it in 23 quarters since. The position peaked at $4.62M in Q4 2021. 332 funds tracked by Wall St. Rank hold TNDM as of Q3 2024.

  • Raymond James Financial Services Advisors held 17,189 shares of Tandem Diabetes Care worth $729K as of Q3 2024.
  • Raymond James Financial Services Advisors bought 494 Tandem Diabetes Care shares in Q3 2024, an estimated $20.9K.
  • Tandem Diabetes Care made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #2381 holding.
  • Raymond James Financial Services Advisors first reported a position in Tandem Diabetes Care in Q3 2018 and has held it in 23 quarters since.
  • Raymond James Financial Services Advisors's Tandem Diabetes Care position peaked at $4.62M in Q4 2021.
  • 332 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.